<div id="readability-page-1">May 19 (Reuters) - Parabilis Medicines on Tuesday filed for an initial public offering in the United States, according to a regulatory filing, and said it intends to use part of the proceeds to support the development of its drug pipeline. The IPO comes as investor appetite for new listings has improved following strong market debuts by companies such as AI chipmaker Cerebras Systems and</div>

CBRS

<p>生物制药公司 Parabilis Medicines 已在美国提交了首次公开募股（IPO）申请，计划将部分收益用于开发其药物管线。这一举措是在 Cerebras Systems 等公司成功上市后，投资者对新上市公司的兴趣重新升温之际进行的</p>

生物制药公司 Parabilis Medicines 申请在美国进行首次公开募股